Physician profile
Travis Gratton
NPI 1144648684
$5,125.00
in general payments reported to CMS, 2019-2025
16 companies · $693 in 2025
The $693 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $647 · 2020: $434 · 2021: $291 · 2022: $1,390 · 2023: $1,013 · 2024: $657 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,362.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $588.67 | 2021-2025 | Repatha, Repatha |
| Abbott Laboratories | $570.27 | 2022-2025 | Diamondback Coronary, Mitraclip |
| Abiomed | $565.03 | 2022-2024 | Impella |
| Medtronic Vascular, INC. | $541.40 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $424.83 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $395.47 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Heartflow, INC. | $317.24 | 2024-2025 | |
| Boston Scientific Corporation | $290.73 | 2019-2022 | |
| Terumo Medical Corporation | $242.13 | 2021-2022 | |
| Pfizer INC. | $222.93 | 2024-2025 | |
| Biotronik INC. | $218.76 | 2023-2025 | Orsiro Mission, Recross |
| Novartis Pharmaceuticals Corporation | $215.71 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $159.80 | 2020-2025 | Camzyos, Eliquis |
| Shockwave Medical, INC | $147.87 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $124.01 | 2023-2024 | Xarelto |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $100.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Gratton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.